Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00SWQ
|
||||
Former ID |
DNCL002891
|
||||
Drug Name |
Mitoglitazone
|
||||
Synonyms |
MSDC-0160; Mitoglitazone (TN)
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Phase 2 | [523005] | ||
Company |
Metabolic Solutions Development
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H18N2O4S
|
||||
Canonical SMILES |
CCC1=CN=C(C=C1)C(=O)COC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
|
||||
InChI |
1S/C19H18N2O4S/c1-2-12-5-8-15(20-10-12)16(22)11-25-14-6-3-13(4-7-14)9-17-18(23)21-19(24)26-17/h3-8,10,17H,2,9,11H2,1H3,(H,21,23,24)
|
||||
InChIKey |
IRNJSRAGRIZIHD-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Insulin receptor | Target Info | Modulator | [532846] | |
KEGG Pathway | Ras signaling pathway | ||||
Rap1 signaling pathway | |||||
cGMP-PKG signaling pathway | |||||
HIF-1 signaling pathway | |||||
FoxO signaling pathway | |||||
PI3K-Akt signaling pathway | |||||
AMPK signaling pathway | |||||
Adherens junction | |||||
Insulin signaling pathway | |||||
Ovarian steroidogenesis | |||||
Type II diabetes mellitus | |||||
Non-alcoholic fatty liver disease (NAFLD) | |||||
Aldosterone-regulated sodium reabsorption | |||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | Insulin Pathway | ||||
Signaling events mediated by PTP1B | |||||
Signaling events mediated by TCPTP | |||||
Insulin-mediated glucose transport | |||||
PathWhiz Pathway | Insulin Signalling | ||||
Leucine Stimulation on Insulin Signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.